Clinical Trial Update: Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cinacalcet hydrochloride in men with recurrent prostate cancer has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-10-29